Urara Ota

Title: Urara Ota: Innovator in Tumor Diagnostics and Aqueous Formulations

Introduction

Urara Ota is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of medical diagnostics and formulations, holding 2 patents that reflect his innovative spirit and dedication to improving healthcare solutions.

Latest Patents

One of Urara Ota's latest patents is an aqueous formulation containing 5-aminolevulinic acid (ALA) or similar compounds. The objective of this invention is to enhance the stability of an aqueous formulation that includes ALAs and an iron compound. This formulation is characterized by the inclusion of 0.2-30% by weight of sodium or potassium salts, with a pH range of 2-8.

Another significant patent is a diagnostic agent for tumors. This invention aims to provide a method for determining the presence or absence of a tumor in a subject, as well as distinguishing between malignant and benign tumors. The method involves the oral administration of ALA at a dose of 5 to 7 mg per kg of body weight, followed by the collection of a urine sample 4 to 12 hours post-administration. The quantification of porphyrins and creatinine in the urine allows for a clear distinction among individuals without tumors, those with benign tumors, and those with malignant tumors.

Career Highlights

Urara Ota has worked with reputable organizations such as Sbi Pharmaceuticals Co., Ltd. and Osaka City University. His experience in these institutions has contributed to his expertise in the development of innovative medical solutions.

Collaborations

Some of his notable coworkers include Masahiro Ishizuka and Mika Morishita, who have collaborated with him on various projects.

Conclusion

Urara Ota's contributions to the fields of aqueous formulations and tumor diagnostics highlight his role as an innovative inventor. His work continues to pave the way for advancements in medical technology and patient care.